Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Terminated 3Unknown 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 16Endocrine 16CNS 4Thoracic 3Sarcoma 3Gastrointestinal 3Breast 3Genitourinary 2NET 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Melanoma 241Carcinoma, Non-Small-Cell Lung 56Carcinoma, Renal Cell 40Skin Neoplasms 39Uveal Melanoma 31Squamous Cell Carcinoma of Head and Neck 30Neoplasms 30Colorectal Neoplasms 27Sarcoma 25Neoplasm Metastasis 25Carcinoma, Merkel Cell 24Ovarian Neoplasms 23Lung Neoplasms 22Stomach Neoplasms 21Carcinoma, Basal Cell 21Breast Neoplasms 20Head and Neck Neoplasms 18Esophageal Neoplasms 16Uterine Cervical Neoplasms 15Pancreatic Neoplasms 15Carcinoma, Hepatocellular 15Lymphoma, T-Cell, Cutaneous 14Urinary Bladder Neoplasms 13Triple Negative Breast Neoplasms 13Prostatic Neoplasms 13Carcinoma, Transitional Cell 13Brain Neoplasms 13Thyroid Neoplasms 11Small Cell Lung Carcinoma 10Mycosis Fungoides 10

Interventions

entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Thyroid Cancer, Papillary × Dermatologic × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡